ARCHIVES

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

“Wild West” of Molecular Testing?: Caris Engaged in Aggressive Marketing, Improper Medicare Billing, Lawsuit Alleges

August 8, 2014

Conference On Delayed Consequences Of Cancer Therapy Scheduled Jan. 9-11

January 3, 1975

In Brief: ACR Moving To D.C.; FDA Advisors OK VP-16 NDA; Wiernik Tells Missouri No; Dewys Moves To DRCCA

October 15, 1982

Basic Research Group Seeks $7.9 Billion For NIH, $1.7 For NCI

July 24, 1987

Also Anna Barker gets new, longer title at NCI; Mark Clanton named deputy director for care, delivery.

February 13, 2004

In Brief: Curt Appointment Now Official; Bipartisan Effort Seeks $150 Million FDA Budget Increase

April 21, 1989